With support from Markwayne Mullin and Robert F. Kennedy Jr., the kratom industry is pursuing a potentially lucrative policy. Mr. Mullin owns equity in a company that could benefit.
Clinical trials in China are getting attention at an international oncology gathering in Chicago. Chinaβs surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.